Ensign Peak Advisors, Inc - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 185 filers reported holding ASCENDIS PHARMA A/S in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.8%.

Quarter-by-quarter ownership
Ensign Peak Advisors, Inc ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$6,324,820
+4.7%
67,544
-0.2%
0.01%
+16.7%
Q2 2023$6,041,600
-16.8%
67,6930.0%0.01%
-25.0%
Q1 2023$7,258,044
-12.2%
67,6930.0%0.02%
-15.8%
Q4 2022$8,267,346
+247.5%
67,693
+193.8%
0.02%
+216.7%
Q3 2022$2,379,000
+11.1%
23,0430.0%0.01%
+20.0%
Q2 2022$2,142,000
+8.6%
23,043
+37.1%
0.01%
+25.0%
Q1 2022$1,972,000
-27.7%
16,806
-17.1%
0.00%
-20.0%
Q4 2021$2,728,000
-3.2%
20,281
+14.7%
0.01%
-16.7%
Q3 2021$2,819,000
-25.3%
17,685
-38.3%
0.01%
-25.0%
Q2 2021$3,774,000
-56.2%
28,685
-57.1%
0.01%
-57.9%
Q1 2021$8,620,000
+34.8%
66,882
+74.4%
0.02%
+26.7%
Q4 2020$6,395,000
-18.8%
38,345
-24.9%
0.02%
-25.0%
Q3 2020$7,876,000
+16.6%
51,040
+11.8%
0.02%
+11.1%
Q2 2020$6,755,000
+39.6%
45,669
+6.3%
0.02%
+12.5%
Q1 2020$4,838,000
-29.5%
42,958
-12.9%
0.02%
-11.1%
Q4 2019$6,861,00049,3140.02%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q3 2022
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders